Clinical Trials Browser

Terminated × selinexor × Thoracic × Clear all

NCT03095612 2024-06-13

Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Terminated

41 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

NCT02351505 2016-05-16

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 6 charts

Small Cell Lung Carcinoma